24 Results | Everything | Search

Product TypeClear Filters

Analytical Chemistry (1)

Biochemicals (18)

Environmental Toxicology (1)

Lipid Nanoparticles (LNPs) (2)

Lipids (5)

Natural Products (4)

Proteins (2)

Small Molecule Modulators (20)

Research AreaClear Filters

Cancer (24)

Angiogenesis (1)

Cell Cycle (3)

Cell Death (10)

Cell Signaling (24)

ERK/MAPK Signaling (1)

Growth Factor Receptor Signaling (2)

JAK/STAT Signaling (1)

NF-κB Signaling (1)

PI3K/Akt/mTOR Signaling (3)

PKC Signaling (24)

ROCK Signaling (1)

Multidrug Resistance (1)

Transcription Factors (1)

Cardiovascular System (1)

Cell Biology (8)

Endocrinology & Metabolism (1)

Epigenetics, Transcription, & Translation (2)

Immunology & Inflammation (5)

Infectious Disease (2)

Lipid Biochemistry (5)

Neuroscience (3)

Oxidative Stress & Reactive Species (1)

Plant Biology (1)

ApplicationClear Filters

Enzyme Activity (1)

Mass Spectrometry (1)

Displaying 1 - 24 of 24 Results

Phorbol 12-myristate 13-acetate

A PKC activator

CAS No. 16561-29-8

Item No. 10008014

Formulation: A solid

Purity: ≥95%

PMA
12-O-Tetradecanoylphorbol-13-acetate
TPA

1 mg

$43

Add

5 mg

$172

Add

10 mg

$280

Add

25 mg

$537

Add

Gö 6976

A PKCα/β1 inhibitor

CAS No. 136194-77-9

Item No. 13310

Formulation: A crystalline solid

Purity: ≥98%

PD 406976

500 µg

$54

Add

1 mg

$102

Add

5 mg

$238

Add

Calphostin C

A selective PKC inhibitor

CAS No. 121263-19-2

Item No. 15383

Formulation: A solid

Purity: ≥95%

Cladochrome E
PKF 115-584
UCN 1028C

100 µg

$157

Add

500 µg

$664

Add

PKC 412

Kinase inhibitor with potential use in cancer treatment

CAS No. 120685-11-2

Item No. 10459

Formulation: A crystalline solid

Purity: ≥98%

N-Benzoylstaurosporine
CGP 41231
CGP 41251
Midostaurin

1 mg

$31

Add

5 mg

$93

Add

10 mg

$154

Add

25 mg

$270

Add

Bryostatin 1

A marine macrolide with diverse biological activities

CAS No. 83314-01-6

Item No. 14802

Formulation: A lyophilized powder

Purity: ≥98%

NSC 339555

10 µg

$655

Add

2-hydroxy Oleic Acid-d₁₇

An internal standard for the quantification of 2-hydroxy oleic acid

CAS No. 1346606-40-3

Item No. 9004307

Formulation: A solution in methyl acetate

Purity: ≥99% deuterated forms (d₁-d₁₇)

FA 18:1;O-d₁₇
2-HOME-d₁₇
2-hydroxy-cis-9-Octadecenoic Acid-d₁₇
α-hydroxy-cis-9-Octadecenoic Acid-d₁₇
2-hydroxy-9(Z)-OME-d-d₁₇
2-Hydroxyoctadecenoic Acid-d₁₇
2-OHOA-d₁₇

100 µg

$142

Add

250 µg

$284

Add

500 µg

$498

Add

UCN-01

A nonspecific protein kinase inhibitor

CAS No. 112953-11-4

Item No. 18130

Formulation: A 1 mg/ml solution in ethanol

Purity: ≥95%

NSC 638850
7-hydroxy Staurosporine

1 mg

$197

Add

Chelerythrine (chloride)

Potent inhibitor of PKC and Bcl-xL

CAS No. 3895-92-9

Item No. 11314

Formulation: A crystalline solid

Purity: ≥98%

Broussonpapyrine chloride
NSC 646662

1 mg

$36

Add

5 mg

$70

Add

10 mg

$120

Add

25 mg

$209

Add

Safingol

A dual inhibitor of PKC and SPHK

CAS No. 15639-50-6

Item No. 18624

Formulation: A crystalline solid

Purity: ≥98%

L-threo-Dihydrosphingosine
L-threo-Sphinganine

1 mg

$87

Add

5 mg

$322

Add

10 mg

$556

Add

25 mg

$970

Add

Enzastaurin

An inhibitor of PKC and Akt signaling

CAS No. 170364-57-5

Item No. 11601

Formulation: A crystalline solid

Purity: ≥98%

LY317615

5 mg

$95

Add

10 mg

$134

Add

25 mg

$281

Add

50 mg

$467

Add

Ingenol

A PKC activator

CAS No. 30220-46-3

Item No. 14031

Formulation: A crystalline solid

Purity: ≥98%

500 µg

$38

Add

1 mg

$65

Add

5 mg

$274

Add

10 mg

$399

Add

K252c

A cell-permeable PKC inhibitor

CAS No. 85753-43-1

Item No. 13514

Formulation: A crystalline solid

Purity: ≥98%

SD 1825
Staurosporine aglycone

1 mg

$96

1 mg

$55

Add

5 mg

$203

Add

10 mg

$349

Add

25 mg

$736

Add

CID-2858522

A selective inhibitor of NF-κB activation

CAS No. 758679-97-9

Item No. 14122

Formulation: A crystalline solid

Purity: ≥98%

ML-029

1 mg

$41

Add

5 mg

$80

Add

10 mg

$140

Add

25 mg

$293

Add

CRT0066854

A PKCι and PKCζ inhibitor

CAS No. 1438881-19-6

Item No. 28463

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$54

Add

5 mg

$209

Add

10 mg

$315

Add

PKCα (human, recombinant)

Active • Host: Insect cells • AA: 1-672 (full length) • Tag: N-terminal GST • MW: 102 kDa

Item No. 32563

Formulation: Lyophilized from sterile 40 mM Tris-HCl, pH 8.0, with 110 mM sodium chloride, 2.2 mM potassium chloride, 0.04% Tween 20, 3 mM DTT, 20% glycerol, and 1.6 mM glutathione

Purity: ≥80% estimated by SDS-PAGE

PKCA
PKC-A
PRKCA
Protein Kinase C Alpha Type

10 µg

$400

Add

2-hydroxy Oleic Acid

A synthetic monounsaturated hydroxylated fatty acid

CAS No. 56472-29-8

Item No. 36044

Formulation: A solid

Purity: ≥98%

FA 18:1;O
2-HOME
2-hydroxy-cis-9 -Octadecenoic Acid
α-hydroxy-cis-9 -Octadecenoic Acid
2-hydroxy-9(Z)-OME-d
2-Hydroxyoctadecenoic Acid
2-OHOA

1 mg

$37

Add

5 mg

$118

Add

10 mg

$198

Add

PKCβ Inhibitor

A PKCβ Inhibitor

CAS No. 257879-35-9

Item No. 35494

Formulation: A solid

Purity: ≥98%

Protein Kinase Cβ Inhibitor

5 mg

$146

Add

10 mg

$262

Add

25 mg

$579

Add

50 mg

$1,085

Add

EGFR Peptide (human, mouse) (myristoylated) (trifluoroacetate salt)

A PKC inhibitor

Item No. 36897

Formulation: A solid

Purity: ≥95%

Epidermal Growth Factor Receptor Peptide
Myr-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH
N-myristoyl-RKRTLRRL

5 mg

$54

Add

10 mg

$103

Add

50 mg

$405

Add

PDGF-B (human, recombinant)

Active • Host: Yeast • AA: 82-190 • Tag: N-terminal His • MW: 14.3 kDa

Item No. 44191

Formulation: Lyophilized from sterile 30% acetonitrile and 1/1,000 trifluoroacetic acid

Purity: ≥90% estimated by SDS-PAGE

Becaplermin
IBGC5
PDGF-2
PDGFB
Platelet-Derived Growth Factor B Chain
Platelet-Derived Growth Factor β Polypeptide
Proto-oncogene c-Sis
SIS
SSV

20 µg

$158

Add

50 µg

$296

Add

1 mg

$2,370

Add

Displaying 1 - 24 of 24 Results

Cart Subtotal:$0

Product TypeClear Filters

Research AreaClear Filters

ApplicationClear Filters

Formulation: A solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A lyophilized powder

Purity: ≥98%

Formulation: A solution in methyl acetate

Purity: ≥99% deuterated forms (d1-d17)

Formulation: A 1 mg/ml solution in ethanol

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A 1 mg/ml solution in ethanol

Purity: ≥95%

Formulation: A solid

Purity: ≥95%

Formulation: A solid

Purity: ≥95%

Formulation: A solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: Lyophilized from sterile 40 mM Tris-HCl, pH 8.0, with 110 mM sodium chloride, 2.2 mM potassium chloride, 0.04% Tween 20, 3 mM DTT, 20% glycerol, and 1.6 mM glutathione

Purity: ≥80% estimated by SDS-PAGE

Formulation: A solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Formulation: A solid

Purity: ≥95%

Formulation: Lyophilized from sterile 30% acetonitrile and 1/1,000 trifluoroacetic acid

Purity: ≥90% estimated by SDS-PAGE

Purity: ≥99% deuterated forms (d₁-d₁₇)